2EWL | pdb_00002ewl

Solution structure of the C-terminal domain (monomer) of the HPV45 oncoprotein E7

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D_15N-separated_NOESY	1mM E7 U-15N, 20mM d-TRIS, 100mM NaCl, 90% H2O, 10% D2O	90% H2O/10% D2O	120mM	7.4	ambient	298
2	3D_13C-separated_NOESY	1mM E7 U-15N, 13C, 20mM d-TRIS, 100mM NaCl, 90% H2O, 10% D2O	90% H2O/10% D2O	120mM	7.4	ambient	298
3	HNHA	1mM E7 U-15N, 20mM d-TRIS, 100mM NaCl, 90% H2O, 10% D2O	90% H2O/10% D2O	120mM	7.4	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	600
2	Varian	INOVA	750

NMR Refinement
Method	Details	Software
distance geometry/simulated annealing by CYANA, energy minimisation by OPAL		VNMR

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	15
Representative Model	1 (closest to the average)

Additional NMR Experimental Information
Details	The structure was determined using heteronuclear triple-resonance NMR spectroscopy.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	VNMR	6.1 rev. C
2	data analysis	XEASY	1.3.9	Xia and Bartels
3	structure solution	CYANA	2.1	Guntert et al
4	refinement	OPAL	2.6	Luginbuhl et al

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.